Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Recruiting · NCT03013998 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Biomarker-Based Treatment of Acute Myeloid Leukemia | Previously Untreated Relapsed Refractory Acute Myeloid Leukemia | Recruiting | Phase 2 / Phase 3 | 2026-09-03 | NCT03013998 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AVEO Pharmaceuticals, Inc. | 4 |
| Beat AML, LLC | 2 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 27 |
| Syndax Pharmaceuticals | 16 |
31 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.